PYSZCZYMUKA GREG — SEC Form 4 filings
SEC reporting owner CIK 1952920. 11 Form 4 filings on record with FilingPulse; latest filed 2026-07-30.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-04-02 to 2026-07-30. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 17.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| AYTU BIOPHARMA, INC (AYTU) | Chief Commercial Officer | 8 | — | — | 13 |
| Evoke Pharma Inc (EVOK) | Director | 3 | — | — | 4 |
Form 4 filings — PYSZCZYMUKA GREG
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-30 | 4 | AYTU BIOPHARMA, INC (AYTU) | Grant/award (A): 20,000 @ $0 | EDGAR |
| 2025-12-17 | 4 | Evoke Pharma Inc (EVOK) | Disposition to issuer (D): 5,833 (derivative) · Disposition to issuer (D): 1,155 (derivative) | EDGAR |
| 2025-10-07 | 4 | AYTU BIOPHARMA, INC (AYTU) | Grant/award (A): 12,500 @ $0 | EDGAR |
| 2025-05-22 | 4 | Evoke Pharma Inc (EVOK) | Grant/award (A): 1,155 (derivative) @ $0 | EDGAR |
| 2025-03-31 | 4 | AYTU BIOPHARMA, INC (AYTU) | Option exercise (M): 209 · Option exercise (M): 209 (derivative) @ $0 | EDGAR |
| 2025-02-24 | 4 | Evoke Pharma Inc (EVOK) | Grant/award (A): 5,833 (derivative) @ $0 | EDGAR |
| 2025-01-02 | 4 | AYTU BIOPHARMA, INC (AYTU) | Option exercise (M): 208 · Option exercise (M): 208 (derivative) @ $0 | EDGAR |
| 2024-11-08 | 4 | AYTU BIOPHARMA, INC (AYTU) | Grant/award (A): 7,000 (derivative) @ $0 | EDGAR |
| 2024-10-02 | 4 | AYTU BIOPHARMA, INC (AYTU) | Option exercise (M): 209 · Option exercise (M): 209 (derivative) @ $0 | EDGAR |
| 2024-07-02 | 4 | AYTU BIOPHARMA, INC (AYTU) | Option exercise (M): 208 · Option exercise (M): 208 (derivative) @ $0 | EDGAR |
| 2024-04-02 | 4 | AYTU BIOPHARMA, INC (AYTU) | Option exercise (M): 208 · Option exercise (M): 208 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1952920 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →